The Chk1 inhibitor SAR-020106 sensitizes human glioblastoma cells to irradiation, to temozolomide, and to decitabine treatment

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, October 2019

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 46 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,666 followers.

The Chk1 inhibitor SAR-020106 sensitizes human glioblastoma cells to irradiation, to temozolomide, and to decitabine treatment. https://t.co/3r0F4QR0i4 H/T @NCBI #radonc #PubMed

11 Mar 2020

Reply Repost Favourite

New in Pubmed: "The Chk1 inhibitor SAR-020106 sensitizes human glioblastoma cells to irradiation, to temozolomide, and to decitabine treatment." https://t.co/x4hWD9JjLB

23 Oct 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.